February 1, 2023
February 01, 2023 - IBSA Pharma Inc. is voluntarily recalling 27 lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution
to the consumer level
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
GlobalReach Health
February 1, 2023
February 01, 2023 - Shop Me Ca of Herndon, VA is recalling its 10-gram tubes of “Diep Bao Cream” because they have the
potential to be contaminated with lead
February 1, 2023
February 1, 2023 - The U.S. Food and Drug Administration approved Jesduvroq tablets (daprodustat) as
the first oral treatment for anemia (decreased number of red
January 31, 2023
January 31, 2023 - FDA published draft guidance for industry, “M13A Bioequivalence for Immediate-
Release Solid Oral Dosage Forms
January 30, 2023
January 30th, 2023 – The Menarini Group, a leading Italian pharmaceutical and diagnostics company, has announced that the U.S. Food and Drug Administration
January 27, 2023
January 27, 2023 - Loxo@Lilly, the oncology unit of Eli Lilly and Company announced that the U.S. Food
and Drug Administration approved Jaypirca
January 23, 2023
January 23, 2023 - The U.S. Food and Drug Administration has approved zanubrutinib (Brukinsa),
manufactured by the biotechnology company BeiGene, which is a next-generation BTK inhibitor
January 23, 2023
January 23, 2023 - TheracosBio has announced that the U.S. Food and Drug Administration (FDA) has approved Brenzavvy (bexagliflozin), an oral sodium-glucose